## **Core Concept**
Gaucher's disease is a genetic disorder characterized by the accumulation of a specific type of lipid within cells due to a deficiency of the enzyme glucocerebrosidase. This accumulation primarily occurs in macrophages, leading to various systemic manifestations.

## **Why the Correct Answer is Right**
The correct answer, **Glucocerebroside**, is right because Gaucher's disease results from a deficiency of the enzyme glucocerebrosidase, which is responsible for breaking down glucocerebroside into glucose and ceramide. Without sufficient glucocerebrosidase activity, glucocerebroside accumulates within lysosomes of macrophages, forming Gaucher cells, which are characteristic of the disease.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because while cerebrosides are related to the pathophysiology of Gaucher's disease, the specific accumulation in Gaucher's disease is of glucocerebroside, not cerebroside in general.
- **Option B:** This option is incorrect because gangliosides are a different type of glycosphingolipid and are not the primary substance accumulating in Gaucher's disease.
- **Option C:** This option is incorrect because although phospholipids are a class of lipids, the specific issue in Gaucher's disease is with glucocerebroside, a type of glycosphingolipid.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that Gaucher's disease is treated with enzyme replacement therapy (ERT) using recombinant glucocerebrosidase, and in some cases, substrate reduction therapy. Early diagnosis and treatment can significantly improve outcomes for patients.

## **Correct Answer:** . Glucocerebroside